Schizophrenia
Biological Causes of Schizophrenia
Real-World Application of Classical Conditioning
Healthcare Agencies II
Secondary Healthcare System
Tertiary Healthcare System
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 24, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Saartje Burgmans1, Anne Rieper Hald2, Sayagi Tina Markandaier3
1Boehringer Ingelheim, 1043 AP Amsterdam, The Netherlandsrafael.loiseau@boehringer-ingelheim.com (R.L.); xandra.lie@boehringer-ingelheim.com (X.L.).
Systemic barriers, not clinical uncertainty, limit patient access to innovative schizophrenia care. Improving care requires strengthening early identification, rehabilitation services, and aligning reimbursement with long-term outcomes.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: